Wednesday, July 05, 2017 8:20:31 AM
The doctors say as much as they can right up to the cystoscope question.
Phase 2 is the critical (no phase 3 required)
3/10 for drug approval for 'response rate'
The odds are heavily stacked in our favour.. I mean lol.. I expect the low dose to give us 3/3 alone.
When Dr.Jewett talked about the previous trial vs this one..... easy to see in 2017 where the technology has advanced to with micro-calculations and mini equipment to do things we couldn't do in 1998
*salute*
Just hope we can boost the pps before the next fundraise
Love stocks that have; Revenues, No Toxic Debts & Innovative project ambitions.
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM